Optimization of Fluorescently Labeled Nrf2 Peptide Probes and the Development of a Fluorescence Polarization Assay for the Discovery of Inhibitors of Keap1-Nrf2 Interaction

Overview

Journal J Biomol Screen

Publisher Sage Publications

Date 2011 Dec 14

PMID 22156223

Citations 42

Authors

Daigo Inoyama

Yu Chen

Xinyi Huang

Lesa J Beamer

Ah-Ng Tony Kong

Longqin Hu

Affiliations

Soon will be listed here.

Abstract

Activation of the antioxidant response element (ARE) upregulates enzymes involved in detoxification of electrophiles and reactive oxygen species. The induction of ARE genes is regulated by the interaction between redox sensor protein Keap1 and the transcription factor Nrf2. Fluorescently labeled Nrf2 peptides containing the ETGE motif were synthesized and optimized as tracers in the development of a fluorescence polarization (FP) assay to identify small-molecule inhibitors of the Keap1-Nrf2 interaction. The tracers were optimized to increase the dynamic range of the assay and their binding affinities to the Keap1 Kelch domain. The binding affinities of Nrf2 peptide inhibitors obtained in our FP assay using FITC-9mer Nrf2 peptide amide as the probe were in good agreement with those obtained previously by a surface plasmon resonance assay. The FP assay exhibits considerable tolerance toward DMSO and produced a Z' factor greater than 0.6 in a 384-well format. Further optimization of the probe led to cyanine-labeled 9mer Nrf2 peptide amide, which can be used along with the FITC-9mer Nrf2 peptide amide in a high-throughput screening assay to discover small-molecule inhibitors of Keap1-Nrf2 interaction.

Citing Articles

New Insights into Antioxidant Peptides: An Overview of Efficient Screening, Evaluation Models, Molecular Mechanisms, and Applications.

Zhang Y, Li Y, Quan Z, Xiao P, Duan J Antioxidants (Basel). 2024; 13(2).

PMID: 38397801 PMC: 10886007. DOI: 10.3390/antiox13020203.

Structure-based design and optimization of a new class of small molecule inhibitors targeting the P-stalk binding pocket of ricin.

Rudolph M, Dutta A, Tsymbal A, McLaughlin J, Chen Y, Davis S Bioorg Med Chem. 2024; 100:117614.

PMID: 38340640 PMC: 11418912. DOI: 10.1016/j.bmc.2024.117614.

Target-based drug discovery: Applications of fluorescence techniques in high throughput and fragment-based screening.

Kumar V, Lakshman P, Prasad T, Manjunath K, Bairy S, Vasu A Heliyon. 2024; 10(1):e23864.

PMID: 38226204 PMC: 10788520. DOI: 10.1016/j.heliyon.2023.e23864.

Structural modification of C2-substituents on 1,4-bis(arylsulfonamido)benzene or naphthalene-N,N'-diacetic acid derivatives as potent inhibitors of the Keap1-Nrf2 protein-protein interaction.

Lee S, Ali A, Abed D, Nguyen M, Verzi M, Hu L Eur J Med Chem. 2023; 265:116104.

PMID: 38159482 PMC: 10794003. DOI: 10.1016/j.ejmech.2023.116104.

Targeting Protein-Protein Interfaces with Peptides: The Contribution of Chemical Combinatorial Peptide Library Approaches.

Monti A, Vitagliano L, Caporale A, Ruvo M, Doti N Int J Mol Sci. 2023; 24(9).

PMID: 37175549 PMC: 10178479. DOI: 10.3390/ijms24097842.

References

MacLeod A, McMahon M, Plummer S, Higgins L, Penning T, Igarashi K . Characterization of the cancer chemopreventive NRF2-dependent gene battery in human keratinocytes: demonstration that the KEAP1-NRF2 pathway, and not the BACH1-NRF2 pathway, controls cytoprotection against electrophiles as well as redox-cycling.... Carcinogenesis. 2009; 30(9):1571-80. PMC: 3656619. DOI: 10.1093/carcin/bgp176. View

Beamer L, Li X, Bottoms C, Hannink M . Conserved solvent and side-chain interactions in the 1.35 Angstrom structure of the Kelch domain of Keap1. Acta Crystallogr D Biol Crystallogr. 2005; 61(Pt 10):1335-42. DOI: 10.1107/S0907444905022626. View

Eggler A, Liu G, Pezzuto J, van Breemen R, Mesecar A . Modifying specific cysteines of the electrophile-sensing human Keap1 protein is insufficient to disrupt binding to the Nrf2 domain Neh2. Proc Natl Acad Sci U S A. 2005; 102(29):10070-5. PMC: 1177374. DOI: 10.1073/pnas.0502402102. View

Wu X, Hu L . Efficient amidation from carboxylic acids and azides via selenocarboxylates: application to the coupling of amino acids and peptides with azides. J Org Chem. 2007; 72(3):765-74. DOI: 10.1021/jo061703n. View

Chen Y, Inoyama D, Kong A, Beamer L, Hu L . Kinetic analyses of Keap1-Nrf2 interaction and determination of the minimal Nrf2 peptide sequence required for Keap1 binding using surface plasmon resonance. Chem Biol Drug Des. 2011; 78(6):1014-21. PMC: 3218206. DOI: 10.1111/j.1747-0285.2011.01240.x. View

Lo S, Li X, Henzl M, Beamer L, Hannink M . Structure of the Keap1:Nrf2 interface provides mechanistic insight into Nrf2 signaling. EMBO J. 2006; 25(15):3605-17. PMC: 1538563. DOI: 10.1038/sj.emboj.7601243. View

Taguchi K, Motohashi H, Yamamoto M . Molecular mechanisms of the Keap1–Nrf2 pathway in stress response and cancer evolution. Genes Cells. 2011; 16(2):123-40. DOI: 10.1111/j.1365-2443.2010.01473.x. View

Dinkova-Kostova A, Holtzclaw W, Kensler T . The role of Keap1 in cellular protective responses. Chem Res Toxicol. 2005; 18(12):1779-91. DOI: 10.1021/tx050217c. View

Rushmore T, Morton M, Pickett C . The antioxidant responsive element. Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity. J Biol Chem. 1991; 266(18):11632-9. View

10.

Zipper L, Mulcahy R . The Keap1 BTB/POZ dimerization function is required to sequester Nrf2 in cytoplasm. J Biol Chem. 2002; 277(39):36544-52. DOI: 10.1074/jbc.M206530200. View

11.

Motohashi H, Yamamoto M . Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol Med. 2004; 10(11):549-57. DOI: 10.1016/j.molmed.2004.09.003. View

12.

Hur W, Gray N . Small molecule modulators of antioxidant response pathway. Curr Opin Chem Biol. 2011; 15(1):162-73. DOI: 10.1016/j.cbpa.2010.12.009. View

13.

Zhang D, Hannink M . Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. Mol Cell Biol. 2003; 23(22):8137-51. PMC: 262403. DOI: 10.1128/MCB.23.22.8137-8151.2003. View

14.

Zhang , Chung , OLDENBURG . A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays. J Biomol Screen. 2000; 4(2):67-73. DOI: 10.1177/108705719900400206. View

15.

Nasir M, Jolley M . Fluorescence polarization: an analytical tool for immunoassay and drug discovery. Comb Chem High Throughput Screen. 1999; 2(4):177-90. View

16.

Slocum S, Kensler T . Nrf2: control of sensitivity to carcinogens. Arch Toxicol. 2011; 85(4):273-84. DOI: 10.1007/s00204-011-0675-4. View

17.

Kimura M, Yamamoto T, Zhang J, Itoh K, Kyo M, Kamiya T . Molecular basis distinguishing the DNA binding profile of Nrf2-Maf heterodimer from that of Maf homodimer. J Biol Chem. 2007; 282(46):33681-33690. DOI: 10.1074/jbc.M706863200. View

18.

Kobayashi M, Itoh K, Suzuki T, Osanai H, Nishikawa K, Katoh Y . Identification of the interactive interface and phylogenic conservation of the Nrf2-Keap1 system. Genes Cells. 2002; 7(8):807-20. DOI: 10.1046/j.1365-2443.2002.00561.x. View

19.

Kobayashi A, Kang M, Okawa H, Ohtsuji M, Zenke Y, Chiba T . Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol Cell Biol. 2004; 24(16):7130-9. PMC: 479737. DOI: 10.1128/MCB.24.16.7130-7139.2004. View

20.

Zhang D, Lo S, Cross J, Templeton D, Hannink M . Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex. Mol Cell Biol. 2004; 24(24):10941-53. PMC: 533977. DOI: 10.1128/MCB.24.24.10941-10953.2004. View